Bingham Gwendolyn M
Known title: DirectorCIK: 0001804960
Associated companies
Transaction History
| ACH | ▼ Sell | Open Market | 7,600 | $268K | 5/12/2022 | View on chart |
| ACH | ▲ Buy | Grant | 4,931 | $0 | 4/29/2022 | View on chart |
| ACH | ▼ Sell | Open Market | 7,600 | $268K | 5/12/2022 | View on chart |
| ACH | ▲ Buy | Grant | 4,931 | $0 | 4/29/2022 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Accendra Health Receives NYSE Continued Listing Notice
Accendra Health received a notice from the NYSE regarding continued listing standards, with the company stating its intent to cure the deficiency. This regulatory development adds pressure to a stock that is already trading near its 52-week low. Additionally, Bank of America disclosed a 10.8% stake in the company as of September 30.
Accendra Health Receives NYSE Continued Listing Notice. Accendra Health received a notice from the NYSE regarding continued listing standards, with the company stating its intent to cure the deficiency. This regulatory development adds pressure to a stock that is already trading near its 52-week low. Additionally, Bank of America disclosed a 10.8% stake in the company as of September 30.